Theramu Appoints Big Brand CEO to Lead Rapidly Growing Demand for Superior Hemp-Based Products

04:28 EDT 29 Jun 2017 | PR Newswire

BAKERSFIELD, Calif., June 29, 2017 /PRNewswire/ -- Theramu, LLC today announced the appointment of Joel Greengrass, top executive from powerhouse brands including Buzzfeed, FanDuel, ideeli, Inc. and Equinox. This acquisition of talent from outside the cannabis space is intentional, recognizing the growing industry requires top-notch leadership, the latest technology and savvy revenue growth strategies.

The launch of Theramu's PRO line was the primary catalyst for Greengrass' appointment. The management team knew they had a superior product that could improve the lives of many people with the right leadership at the helm. Greengrass brings deep expertise in operations and strategic partnerships, and incredible passion for the product, having personally found relief from his own multiple sclerosis symptoms with Theramu. Read about Greengrass:

"What started with a friend sending a bottle of Theramu Relieve, has turned into one of the most exciting, cutting-edge moves of my career," said Joel Greengrass, Theramu CEO. "Not only do I have full confidence in the product and company mission, I am thrilled to establish an entirely new method of distribution and accelerate the industry's first-ever, revenue-share strategy through physician and wellness practices nationwide."

Healthcare Industry Opportunity Proprietary research conducted by Theramu showed approximately 50% of healthcare and wellness professionals across the country are "willing to try an all-natural, revolutionary, alternative, anti-inflammatory analgesic that is a THC-free cannabidiol based product". Further, just over 50% believe their patients would be likely to try a product of this type at their recommendation.

"Theramu has proven to be an effective, safe, natural alternative for my patients suffering with craniofacial and cervical pain," said Board-Certified Craniofacial Pain Specialist Joseph N. Tregaskes, D.M.D., M.S. "The proprietary formula developed with the highest quality and purity Cannabidiol and EFA-rich Emu Oil supports the human endocannabinoid system, bringing natural relief to my patients suffering with chronic TMD, head, neck and facial pain, and associated anxiety."

Theramu Products Theramu offers six initial products, available to consumers and wellness professionals nationwide at Topicals include Relieve and Relieve with Menthol, and a sublingual elixir, Calm. Each product comes in two strengths to support various levels of discomfort. The PRO strength products also are sold by professionals wishing to offer patients an all-natural option as part of treatment plans.

About Theramu Theramu products were developed as safe all-natural alternatives to improve people's lives by supporting numerous functions of the human body. The proprietary compound of 100% Cannabidiol and EFA-rich pure Emu Oil soothes chronic aches and discomfort, promotes vital cellular renewal, restores and repairs skin, and provides #TheramuRelief for a balanced mind and body. Decades of evidence demonstrate indisputable positive health outcomes and safety of pure hemp extract. The US government owns patent 6630507, further documenting cannabinoids potential application for many inflammatory conditions. Theramu's ideals support the movement toward safe, patient-centric, whole-person healthcare.

Media Contact Megan Lozito
Beanstalk Digital 

To view the original version on PR Newswire, visit:



More From BioPortfolio on "Theramu Appoints Big Brand CEO to Lead Rapidly Growing Demand for Superior Hemp-Based Products"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.